Article Details

MabVax Therapeutics Receives Superseding Letter Related to the Late Filing of Form 10-Q

Retrieved on: 2018-06-27 07:26:15

Tags for this article:

Click the tags to see associated articles and topics

MabVax Therapeutics Receives Superseding Letter Related to the Late Filing of Form 10-Q. View article details on hiswai:

Excerpt

<div>The Nasdaq notice has no immediate effect on the listing or trading of the Company's common <b>stock</b> on The Nasdaq Capital Market. However, under ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up